Lucie Y. Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucie Y. Guo has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Alexander E. Davis
Stanford University School of Medicine
2 shared publicationsAugustine Chemparathy
Stanford University School of Medicine
2 shared publicationsBaokun Gu
Stanford University School of Medicine
2 shared publications- Charles DeBoer
Department of Ophthalmology, School of Medicine, Byers Eye Institute at Stanford University, Palo Alto, USA
2 shared publications Hannah R. Kempton
Stanford University School of Medicine
2 shared publicationsJing Bian
Stanford University School of Medicine
2 shared publications
Latest Publications
- Open Access
Foreign Body Presenting as Golden Hypopyon
Background/Objectives: Penetrating intraocular foreign bodies (IOFBs) are ocular emergencies, often leading to preventable vision loss. This case report highlights a unique presentation of a work-related penetrating IOFB that mimicked a golden hypopyon. Methods: A 35-year-old male presented to the emergency department with sudden-onset pain and vision loss in the left eye while he was cutting a tree with metallic scissors. He had a visual acuity of 20/30 in the right eye and counting fingers in the left eye. A dilated slit-lamp examination and CT scan confirmed the presence of a 6–8 mm metallic IOFB in the anterior chamber, with no involvement of the lens or the posterior segment. Surgical removal was performed. Results: The metallic IOFB was removed surgically with IOFB forceps using a single paracentesis. The patient reported resolving pain and regained baseline visual acuity of 20/20 postoperatively, which remained stable at one-month follow-up. Conclusions: This case illustrates the successful surgical management of a penetrating metallic IOFB with a unique presentation mimicking a hypopyon. Emphasis on unique presentations of IOFBs can aid in timely management, ultimately reducing the risk of complications.
Open AccessForeign Body Presenting as Golden Hypopyon
Background/Objectives: Penetrating intraocular foreign bodies (IOFBs) are ocular emergencies, often leading to preventable vision loss. This case report highlights a unique presentation of a work-related penetrating IOFB that mimicked a golden hypopyon. Methods: A 35-year-old male presented to the emergency department with sudden-onset pain and vision loss in the left eye while he was cutting a tree with metallic scissors. He had a visual acuity of 20/30 in the right eye and counting fingers in the left eye. A dilated slit-lamp examination and CT scan confirmed the presence of a 6–8 mm metallic IOFB in the anterior chamber, with no involvement of the lens or the posterior segment. Surgical removal was performed. Results: The metallic IOFB was removed surgically with IOFB forceps using a single paracentesis. The patient reported resolving pain and regained baseline visual acuity of 20/20 postoperatively, which remained stable at one-month follow-up. Conclusions: This case illustrates the successful surgical management of a penetrating metallic IOFB with a unique presentation mimicking a hypopyon. Emphasis on unique presentations of IOFBs can aid in timely management, ultimately reducing the risk of complications.
- Open Access
- 17 October 2024
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 36, 102188
Retinal racemose hemangioma presenting with a chorioretinal anastomosis
- 17 October 2024
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 36, 102188
Open AccessRetinal racemose hemangioma presenting with a chorioretinal anastomosis
- Open Access
- 8 March 2023
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 30, 101826
Severe progression of pentosan maculopathy over a decade
- 8 March 2023
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 30, 101826
Open AccessSevere progression of pentosan maculopathy over a decade
- Open Access
- 13 April 2022
- Published by Springer Nature in Research Square
Multiplex CRISPR genome regulation in mouse retina with hyper-efficient Cas12a
CRISPR-Cas nucleases and their nuclease-deactivated dCas variants have revolutionized the field of genome editing and gene regulation. Cas12a possesses intrinsic RNAse activity and can process multiple functional crRNAs from a single long transcript, making it a powerful tool for multiplex gene targeting. We engineered a dCas12a variant termed hyperCas12a with superior efficacy in gene editing and multiplex gene regulation, especially at restrictive crRNA concentrations. Here, we describe a step-by-step protocol for constructing and validating a crRNA array, and using it with the hyperdCas12a system for multiplex gene regulation in vivo by subretinal delivery in mice.
- 13 April 2022
- Published by Springer Nature in Research Square
Open AccessMultiplex CRISPR genome regulation in mouse retina with hyper-efficient Cas12a
CRISPR-Cas nucleases and their nuclease-deactivated dCas variants have revolutionized the field of genome editing and gene regulation. Cas12a possesses intrinsic RNAse activity and can process multiple functional crRNAs from a single long transcript, making it a powerful tool for multiplex gene targeting. We engineered a dCas12a variant termed hyperCas12a with superior efficacy in gene editing and multiplex gene regulation, especially at restrictive crRNA concentrations. Here, we describe a step-by-step protocol for constructing and validating a crRNA array, and using it with the hyperdCas12a system for multiplex gene regulation in vivo by subretinal delivery in mice.
- 12 April 2022
- Published by Springer Nature in Nature Cell Biology
- Vol. 24 (4) , 590-600
Multiplexed genome regulation in vivo with hyper-efficient Cas12a
Multiplexed modulation of endogenous genes is crucial for sophisticated gene therapy and cell engineering. CRISPR–Cas12a systems enable versatile multiple-genomic-loci targeting by processing numerous CRISPR RNAs (crRNAs) from a single transcript; however, their low efficiency has hindered in vivo applications. Through structure-guided protein engineering, we developed a hyper-efficient Lachnospiraceae bacterium Cas12a variant, termed hyperCas12a, with its catalytically dead version hyperdCas12a showing significantly enhanced efficacy for gene activation, particularly at low concentrations of crRNA. We demonstrate that hyperdCas12a has comparable off-target effects compared with the wild-type system and exhibits enhanced activity for gene editing and repression. Delivery of the hyperdCas12a activator and a single crRNA array simultaneously activating the endogenous Oct4, Sox2 and Klf4 genes in the retina of post-natal mice alters the differentiation of retinal progenitor cells. The hyperCas12a system offers a versatile in vivo tool for a broad range of gene-modulation and gene-therapy applications.
- 12 April 2022
- Published by Springer Nature in Nature Cell Biology
- Vol. 24 (4) , 590-600
Multiplexed genome regulation in vivo with hyper-efficient Cas12a
Multiplexed modulation of endogenous genes is crucial for sophisticated gene therapy and cell engineering. CRISPR–Cas12a systems enable versatile multiple-genomic-loci targeting by processing numerous CRISPR RNAs (crRNAs) from a single transcript; however, their low efficiency has hindered in vivo applications. Through structure-guided protein engineering, we developed a hyper-efficient Lachnospiraceae bacterium Cas12a variant, termed hyperCas12a, with its catalytically dead version hyperdCas12a showing significantly enhanced efficacy for gene activation, particularly at low concentrations of crRNA. We demonstrate that hyperdCas12a has comparable off-target effects compared with the wild-type system and exhibits enhanced activity for gene editing and repression. Delivery of the hyperdCas12a activator and a single crRNA array simultaneously activating the endogenous Oct4, Sox2 and Klf4 genes in the retina of post-natal mice alters the differentiation of retinal progenitor cells. The hyperCas12a system offers a versatile in vivo tool for a broad range of gene-modulation and gene-therapy applications.